24 Sep

Moderna’s covid-19 IP pledge is about to be put to the test

The WHO’s African vaccine hub is seeking to imitate Moderna’s mRNA jab. With very low rates of vaccination on the continent, the tech transfer request will shine a new light on the company’s IP sharing commitment

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth